EcoDrugPlus

Presenilin 2

Ensembl ID : ENSSPAG00000001772
Gene Symbol: PSEN2
3 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSSPAG00000014410
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Primary Amine Oxidase, Liver Isozyme-Like

Ensembl ID : ENSSPAG00000011149
Gene Symbol: LOC103371247
3 Cross references
404 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSSPAG00000008859
Gene Symbol: LOC103372307
3 Cross references
250 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSSPAG00000010109
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSPAG00000008971
Gene Symbol: PTGDR2
4 Cross references
134 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSPAG00000013191
Gene Symbol: PTGDR2
3 Cross references
145 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSSPAG00000012334
Gene Symbol: PTGDR2
4 Cross references
134 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSSPAG00000012401
Gene Symbol: PTGER2
3 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSSPAG00000005787
Gene Symbol: PTGER3
3 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSSPAG00000020479
Gene Symbol: PTGER4
3 Cross references
200 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSSPAG00000017836
Gene Symbol: LOC103355958
3 Cross references
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).